Children's Hospital of Philadelphia

With rising interest in inflammation and immunology – likely in response to large deals in the I&I space as much as unmet needs in autoimmune diseases – venture capital investors have put big money in

Merck & Co. Inc. ’s Kim Folander believes collaboration between big pharma and academic or institutional researchers may take on an increasingly important role in pipeline expansion as the competitio

ATLANTA - A multi-center Phase II clinical trial Novartis AG is sponsoring will show whether the Swiss drug maker can scale up a personalized leukemia treatment for global manufacturing. A commerc

IN VITRO DIAGNOSTICS Alliances Aytu BioScience Inc. Durviz SL Parallabs Tani Medikal Teco Medical Instruments GMBH THP Medical Products Vertirebs GMBH Aytu BioScience Inc. granted various partners